Replies to post #96086 on NorthWest Biotherapeutics Inc (NWBO)

[antihama]

I don't think they can, at least that's how I read the following exclusion criteria

History of active immunotherapy, including dendritic cell therapy, T cell therapy, immunization with tumor antigens in any form, any anti-PD-1, anti-PD-L1, anti-PD-L2, or anti-CTLA-4 antibody, or any other antibody or drug specifically targeting T-cell costimulation or immune checkpoint pathways or checkpoint inhibitor therapy such as ipilimumab